Preservation of neutralizing antibody function in COVID-19 convalescent plasma treated using a riboflavin and ultraviolet light-based pathogen reduction technology.

Yonemura, Susan; Hartson, Lindsay; Dutt, Taru S; Henao-Tamayo, Marcela; Goodrich, Raymond; Marschner, Susanne

Yonemura, Susan; Hartson, Lindsay; Dutt, Taru S; Henao-Tamayo, Marcela; Goodrich, Raymond; Marschner, Susanne.

Afiliação

Yonemura S; Terumo Blood and Cell Technologies, Lakewood, CO, USA.
Hartson L; Infectious Disease Research Center, Colorado State University, Fort Collins, CO, USA.
Dutt TS; Department of Microbiology, Immunology & Pathology, Colorado State University, Fort Collins, CO, USA.
Henao-Tamayo M; Department of Microbiology, Immunology & Pathology, Colorado State University, Fort Collins, CO, USA.
Goodrich R; Infectious Disease Research Center, Colorado State University, Fort Collins, CO, USA.
Marschner S; Terumo Blood and Cell Technologies, Lakewood, CO, USA.

Vox Sang ; 116(10): 1076-1083, 2021 Nov.

Article em En | MEDLINE | ID: mdl-33835489

Assuntos

Anticorpos Neutralizantes; COVID-19; Anticorpos Antivirais; COVID-19/terapia; Humanos; Imunização Passiva; Riboflavina; SARS-CoV-2; Tecnologia; Raios Ultravioleta; Soroterapia para COVID-19

Palavras-chave

antibody - function; blood safety; pathogen inactivation; plasma; transfusion therapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticorpos Neutralizantes / COVID-19 Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google